MedTrace Logo

Significance of Serum Tenascin C in Patients With Acute Aortic Disease

NCT02816892 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-06-29

No results posted yet for this study

Summary

This study aims to investigate Serum Tenascin C levels in patients with acute symptoms relating to a known or newly diagnosed aortic aneurysm in emergency department and reveals the possible role of Tenascin C in the development of the disease.

Conditions

  • Aortic Dissection

Sponsors & Collaborators

  • Central South University

    lead OTHER

Principal Investigators

  • Xiangping Chai, M.D. · Second Xiangya Hospital of Central South University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02816892 on ClinicalTrials.gov